Try our Advanced Search for more refined results

Expert Analysis

The Latest Life Sciences Company To Make FCPA Headlines

Law360, New York (November 13, 2014, 10:24 AM EST) -- Over the last several years, multinational companies of various sizes and geographical reach in the pharmaceutical, medical device and biotechnology industries have found themselves in the crosshairs of the U.S. Department of Justice and U.S. Securities and Exchange Commission as both agencies continue their aggressive enforcement of the Foreign Corrupt Practices Act. Many such life sciences companies have already resolved FCPA matters with the U.S. government, and numerous others have disclosed that they are subject to ongoing investigations....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!